Stock UniverseDerived research view · source repositories remain read-only

Aktis Oncology, Inc. (AKTS)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
36.84
Global Rank
937
Market Cap
1.06B
Latest Close
18.87
RS Composite
-7.99% · G#1956

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-5.79%
3M
0.32%
6M
-15.76%
1Y
-15.76%
3Y
-15.76%
5Y
-15.76%
10Y
-15.76%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 138.62K · 30-day average: 173.73K · Max drawdown over stored range: -32.19%

Research Snapshot

Relative Strength vs SPX

RS Composite-7.99%
20D RS-0.48%
60D RS-11.75%
120D RSn/a
Global RS Rank1956 · 41.70% percentile
Qualified+ RS Rank726 · 42.29% percentile
Group ScopeQualified+
Primary RS Rank190 · 58.52% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank172 / 701
Primary Percentile75.61
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for AKTS.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2022FY 2023FY 2024FY 2025
Revenue001.4876.497
Revenue Growth (YoY)336.92%
Gross Profit0-25.919-39.467
Operating Income-19.764-34.794-52.05
Free Cash Flow-20.432-33.76811.9-73.711
Free Cash Flow Per Share-39.49-54.88916.899-90.607
EPS (Diluted) GAAP-34.651905-46.554834-62.456952
EPS Growth
EPS Non-GAAP
Gross Margin100%100%
Operating Margin2400%2400%-3500.336%-1149.52%
Profit Margin2400%2400%-2957.633%-980.93%
Free Cash Flow Margin2400%2400%800.269%-1134.54%
Shares Outstanding (Diluted)0.51740.61520.70420.8135
Shares Change (YoY)2400%18.903%14.459%15.53%

SEC Quarterly Fundamentals

No processed quarterly rows for AKTS.